Here, we summarize the biological role of DUX4 and its involvement in FSHD with an emphasis on the cellular and molecular aspects that contribute to the disease and could be targeted for therapeutic purposes. This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.